Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02927769 |
|---|---|
| Brief Title: | A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment (CheckMate 744) |
| First Submitted : | October 6, 2016 |
| First Submitted that Met QC Criteria : | October 6, 2016 |
| First Posted : | October 7, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | August 30, 2022 |
| Last Update Posted : | September 1, 2022 |